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(a) Anti-CaMKII antibody or anti-autophosphorylated-CaMKII (pCaMKII) antibody (diluted 1：1000 in PBS including 0.1％ Triton X-100 and 0.05％ normal goat serum (NGS)) was applied to each slice and incubated at 4°C for 12 h. After washing with PBS, the secondary antibody, FITC-labeled anti-rabbit IgG goat serum (diluted 1：200 in PBS), was allowed to react for 3 h in the dark room at room temperature. Stained sections were mounted in 10％ glycerin-PBS and kept at 4°C in a dark room until measurements were carried out. CaMKII or pCaMKII immuno‰uorescence intensity was analyzed quantitatively using a modiˆed brain mapping analyzer system. (b) To conˆrm antibody speciˆcity, conventional CaMKII and pCaMKII antibodies were absorbed with 1000-fold excess puriˆed and puriˆed/autophosphorylated CaMKII, respectively, before incubation with brain sections. 
